Gold nanoparticles (AuNPs) have been widely used as laser desorption/ionization mass
spectrometry (LDI-MS) nanomaterials for the analysis of low-molecular-weight samples …

Background Although, approximately 30% of the world's population is estimated to be
infected with Toxoplasma gondii (T. gondii) with serious manifestations in …

Toxoplasmosis is one of the widest spread parasitic infections which is caused by
Toxoplasma gondii protozoon. Many experimental studies have evaluated the effect of …

Toxoplasmosis is an opportunistic infection caused by the coccidian Toxoplasma gondii
which represents a food and water contaminant. The available chemotherapeutic agents for …

Latent toxoplasmosis mostly reactivates which could result in acute encephalitis. Chronic
toxoplasmosis treatments are severely constrained by Toxoplasma cyst resistance. Novel …

Toxoplasma gondii is a zoonotic intracellular protozoan parasite and its therapeutic
limitations are one of its major problems. L-citrulline is an organic compound that has …

Toxoplasmosis is an immunologically complex disease, particularly in immunocompromised
patients. Although there are several therapeutic regimens for such disease, the majority of …

Two eco-friendly chromatographic methods were used to simultaneously determine
Spiramycin (SPR) and Metronidazole (MTR) in their pure forms and pharmaceutical …

Side effects and low efficacy of current anti-toxoplasmosis therapeutics against encysted
bradyzoites necessitate research into alternative safe therapeutic options. The safety …

The present study investigated the anti-Toxoplasma effect of chitosan nanoparticles [CS
NPs], spiramycin, spiramycin co-administered with metronidazole and spiramycin-CS NPs …